{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T23:27:21Z","timestamp":1704929241150},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2008,6,26]],"date-time":"2008-06-26T00:00:00Z","timestamp":1214438400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chirurg"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1007\/s00104-008-1553-3","type":"journal-article","created":{"date-parts":[[2008,6,26]],"date-time":"2008-06-26T05:19:39Z","timestamp":1214457579000},"page":"689-696","source":"Crossref","is-referenced-by-count":1,"title":["Metastasen eines unbekannten Prim\u00e4rtumors"],"prefix":"10.1007","volume":"79","author":[{"given":"A.","family":"Sendler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Strumberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Tannapfel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,6,26]]},"reference":[{"key":"1553_CR1","doi-asserted-by":"crossref","unstructured":"Porzsolt F, Wittekind C (2002) Cancer of unknown primary (CUP)-syndrom. Onkologe [Suppl 1] 8: 31\u201334","DOI":"10.1007\/s00761-002-0376-y"},{"key":"1553_CR2","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1200\/JCO.1995.13.8.2094","volume":"13","author":"Abbruzzese","year":"1995","unstructured":"Abbruzzese JL, Abbruzzese MC, Lenzi R et al. (1995) Analysis of a diagnostic strategy for patients with suspected tumors of unknown origin. J Clin Oncol 13: 2094\u20132103","journal-title":"J Clin Oncol"},{"key":"1553_CR3","first-page":"38","volume":"24","author":"Weber","year":"2001","unstructured":"Weber A, Schmoz S, Bootz F (2001) CUP (carcinoma of unknown primary) syndrome in head and neck: clinic, diagnostic, and therapy. Onkologie 24: 38\u201343","journal-title":"Onkologie"},{"key":"1553_CR4","doi-asserted-by":"crossref","first-page":"4679","DOI":"10.1200\/JCO.2002.04.019","volume":"20","author":"Culine","year":"2002","unstructured":"Culine S, Kramar A, Saghatchian M et al. (2002) Development and validation of a prognostic model to predict the length of survival in patients with carcinomas of an unknown primary site. J Clin Oncol 20: 4679\u20134683","journal-title":"J Clin Oncol"},{"key":"1553_CR5","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1053\/crad.2002.1085","volume":"57","author":"Hogan","year":"2002","unstructured":"Hogan BA, Thornton FJ, Brannigan M et al. (2002) Hepatic metastases from an unknown primary neoplasm (UPN): survival, prognostic indicators and value of extensive investigations. Clin Radiol 57: 1073\u20131077","journal-title":"Clin Radiol"},{"key":"1553_CR6","first-page":"MT25","volume":"8","author":"Milovic","year":"2002","unstructured":"Milovic M, Popov I, Jelic S (2002) Tumor markers in metastatic disease from cancer of unknown primary origin. Med Sci Monit 8: MT25\u2013MT30","journal-title":"Med Sci Monit"},{"key":"1553_CR7","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s007610050132","volume":"3","author":"Sandherr","year":"1997","unstructured":"Sandherr M, Rastetter J, Hanauske A-R (1997) Klinik und Grundz\u00fcge der Chemotherapie bei Metastasen eines unbekannten Prim\u00e4rtumors. Onkologe 3: 350\u2013353","journal-title":"Onkologe"},{"key":"1553_CR8","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00292-001-0496-y","volume":"23","author":"Kaufmann","year":"2002","unstructured":"Kaufmann O, Fietze E, Dietel M (2002) Immunohistochemical diagnosis in cancer metastasis of unknown primary tumor. Pathologe 23: 183\u2013197","journal-title":"Pathologe"},{"key":"1553_CR9","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s007610170101","volume":"7","author":"Jenicke","year":"2001","unstructured":"Jenicke L, Bohuslavizki KH, Sonnemann U et al. (2001) FDG-PET in der Bildgebung des CUP-Syndroms. Onkologe 7: 491\u2013497","journal-title":"Onkologe"},{"key":"1553_CR10","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1023\/A:1013107732572","volume":"12","author":"Rades","year":"2001","unstructured":"Rades D, Kuhnel G, Wildfang I et al. (2001) Localised disease in cancer of unknown primary (CUP): the value of positron emission tomography (PET) for individual therapeutic management. Ann Oncol 12: 1605\u20131609","journal-title":"Ann Oncol"},{"key":"1553_CR11","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1007\/s00120-006-1054-2","volume":"45","author":"Seeber","year":"2006","unstructured":"Seeber S, Strumberg D (2006) Metastases with CUP syndrome. Urologe A 45: 614\u2013619","journal-title":"Urologe A"},{"key":"1553_CR12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1089\/108497803321269322","volume":"18","author":"Mantaka","year":"2003","unstructured":"Mantaka P, Baum RP, Hertel A et al. (2003) PET with 2-[F-18]-fluoro-2-deoxy-D-glucose (FDG) in patients with cancer of unknown primary (CUP): influence on patients\u2018 diagnostic and therapeutic management. Cancer Biother Radiopharm 18: 47\u201358","journal-title":"Cancer Biother Radiopharm"},{"key":"1553_CR13","first-page":"3611","volume":"22","author":"Namba","year":"2002","unstructured":"Namba N, Hiraki A, Tabata M et al. (2002) Axillary metastasis as the first manifestation of occult breast cancer in a man: a case report. Anticancer Res 22: 3611\u20133613","journal-title":"Anticancer Res"},{"key":"1553_CR14","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s10434-001-0425-6","volume":"8","author":"Vlastos","year":"2001","unstructured":"Vlastos G, Jean ME, Mirza AN et al. (2001) Feasibility of breast preservation in the treatment of occult primary carcinoma presenting with axillary metastases. Ann Surg Oncol 8: 425\u2013431","journal-title":"Ann Surg Oncol"},{"key":"1553_CR15","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1093\/annonc\/mdg330","volume":"14","author":"Argiris","year":"2003","unstructured":"Argiris A, Smith SM, Stenson K et al. (2003) Concurrent chemoradiotherapy for N2 or N3 squamous cell carcinoma of the head and neck from an occult primary. Ann Oncol 14: 1306\u20131311","journal-title":"Ann Oncol"},{"key":"1553_CR16","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1056\/NEJMoa032641","volume":"350","author":"Bernier","year":"2004","unstructured":"Bernier J, Domenge C, Ozsahin M et al. (2004) Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350: 1945\u20131952","journal-title":"N Engl J Med"},{"key":"1553_CR17","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa032646","volume":"350","author":"Cooper","year":"2004","unstructured":"Cooper JS, Pajak TF, Forastiere AA et al. (2004) Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350: 1937\u20131944","journal-title":"N Engl J Med"},{"key":"1553_CR18","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1053\/ejso.2001.1222","volume":"28","author":"Zuur","year":"2002","unstructured":"Zuur CL, Velthuysen ML van, Schornagel JH et al. (2002) Diagnosis and treatment of isolated neck metastases of adenocarcinomas. Eur J Surg Oncol 28: 147\u2013152","journal-title":"Eur J Surg Oncol"},{"key":"1553_CR19","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s007610050136","volume":"3","author":"Manegold","year":"1997","unstructured":"Manegold C (1997) Therapie von Pleura- und Lungenmetastasen bei Tumorerkrankungen ohne bekannten Prim\u00e4rtumor (CUP). Onkologe 3: 375\u2013379","journal-title":"Onkologe"},{"key":"1553_CR20","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1200\/JCO.2000.18.17.3101","volume":"18","author":"Briasoulis","year":"2000","unstructured":"Briasoulis E, Kalofonos H, Bafaloukos D et al. (2000) Carboplatin plus paclitaxel in unknown primary carcinoma: a phase II Hellenic Cooperative Oncology Group Study. J Clin Oncol 18: 3101\u20133107","journal-title":"J Clin Oncol"},{"key":"1553_CR21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S1040-8428(01)00157-3","volume":"41","author":"Saad","year":"2002","unstructured":"Saad ED, Abbruzzese JL (2002) Prognostic stratification in UPC: a role for assessing the value of conventional-dose and high-dose chemotherapy for unknown primary carcinoma. Crit Rev Oncol Hematol 41: 205\u2013211","journal-title":"Crit Rev Oncol Hematol"}],"container-title":["Der Chirurg"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00104-008-1553-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00104-008-1553-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00104-008-1553-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T03:23:19Z","timestamp":1558581799000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00104-008-1553-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6,26]]},"references-count":21,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["1553"],"URL":"https:\/\/doi.org\/10.1007\/s00104-008-1553-3","relation":{},"ISSN":["0009-4722","1433-0385"],"issn-type":[{"value":"0009-4722","type":"print"},{"value":"1433-0385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6,26]]}}}